Your Flagship ADC Event in Europe
It’s Here! Your Full Event Guide Is Now Live

Speakers

Expert Speaker Faculty Spanning Europe, North America & Asia

Take a look at the esteemed speaker faculty for the 17^th World ADC London Summit.

Global Pharma Leaders

Chief ADC Decision Makers

Innovators, Regulatory Experts, Academic KOLs & ADC Afficionados

Global Pharma Leaders

Isabella Giovinazzo

Senior Scientist, ADC MS&T
Abbvie

ALIREZA TAFAZZOL

Senior Scientist - Oncology Bioinformatics
Abbvie

Alan Russell

VP Research
Amgen

Etsushi Yoshikawa

Scientist
Astellas Pharma

Yutaka Matsuda

Oncology Research Intelligence & Modality Intelligence Lead
Astellas Pharma

Tingting Cui

Associate Director
AstraZeneca

Lakshmi Amaravadi

Head of Oncology Bioanalytical Strategy Team, Clinical Pharmacology & Safety Sciences
AstraZeneca

Daria Galas-Filipowicz

Clinical Pharmacology & Safety Sciences Oncology Safety Postdoctoral Fellow
AstraZeneca

Elena Izquierdo

Senior Associate - Clinical Research
AstraZeneca

Osama Charhrour

Principal Scientist - New Modalities
AstraZeneca

Javad Shahidi

Senior Vice President, Head of Biotech Unit & Development Innovation
BeOne Medicines

Evelyn Fahrenkrug

Global Commercial Head Oncology Pipeline
Boehringer Ingelheim

Ezgi Wood

Associate Director QSP
Bristol Myers Squibb

Grzegorz Nowakowski

Senior Vice President, Head of Global Early Development Organization
Daiichi Sankyo

Corina Taitt

Clinical Development Functional Excellence Head
Daiichi Sankyo

Kyohei Nobori

Principal Scientist, Analytical & Quality Evaluation
Daiichi Sankyo

Hong Zebger-Gong

Senior Medical Director, Global Oncology Clinical Development
Daiichi Sankyo

Pete (Pick-Wei) Lau

Director, Global Regulatory Affairs CMC
Eli Lilly & Co.

Venkatesh Pilla Reddy

Senior Director, Global PKPD & Pharmacometrics
Eli Lilly & Co.

Olivier Marcq

Executive Director
Gilead Sciences

Michael Conner

Senior Principal Scientist – Oncology Research Unit
GlaxoSmithKline

Matt Gray

Scientific Leader
GSK

Elisabetta Leo

Senior Director, Early Development Asset Lead
Ipsen Pharma

Kurt Pike

Senior Director - External Innovation
Johnson & Johnson

Eugenio Cardenal Virgil

Associate Director Regulatory Affiars CMC
Johnson & Johnson

Colleen Santoro

Principal Scientist
Merck & Co

Mike Seganish

Distinguished Scientist, Discovery Chemistry
Merck & Co

Jeroen Janssens

Director Technical Operations
Merck & Co

Jon Travers

Director, Oncology BD&L
Merck & Co

Xiaodong Zhang

Director of Search and Evaluation
Novartis

Chaoran Jing

Principal Scientist
Pfizer

Kevin Hamblett

Senior Director, ADC Pharmacology
Pfizer

Sasha Fraser

Senior Scientist - Bioanalytical Strategy
Regeneron

Yvonne Alice Nagel

External Innovation & Discovery Oncology Lead
Roche

Floriana Cremasco

Senior Scientist
Roche

Ines Grazina de Matos

Principal Scientist
Roche

Irene Blat

Head of External Innovation, North America
Servier

Chief ADC Decision Makers

Paul Jackson

Chief Operating Officer
Adcytherix

Dragan Grabulovski

CEO
Araris Biotech

Bin Zou

Founder & Chief Executive Officer
Axcynsis Therapeutics

Rakesh Dixit

President & Chief Executive Officer
Bionavigen Oncology

Wim dokter

Chief Scientific Officer
Byondis

Giorgio Massimini

CMO
CanWell Pharma

Paul Song

Chief Scientific Officer
Genequantum Healthcare

George Badescu

Chief Business Officer
Heidelberg Pharma

Jerome Boyd-Kirkup

Chief Scientific Officer & Co-Founder
Hummingbird Bioscience

David Simpson

CEO
Iksuda Therapeutics

Robert Lutz

Chief Scientific Officer
Iksuda Therapeutics

Scott Lesley

President & Chief Scientific Officer
InduPro

Jiaqiang Cai

Co-founder ,Chief Scientific Officer & Co-Chief Executive Officer
Medilink Therapeutics

Valerie Vanhooren

Co-Founder & Chief Executive Officer
ONA Therapeutics

Christian Rohlff

Chief Executive Officer & Founder
Oxford BioTherapeutics Ltd

Hua Yang

Chief Scientific Officer
Pharmaron

Samuel Murphy

Vice President & Head of International Business Development
Salubris Biotherapeutics Inc.

Hanspeter Gerber

Chief Scientific Officer
Sutro Bio

Kieron Hall

Chief Commercial Officer
Sygnature Discovery

Harold Keer

Chief Medical Officer
Taiho Oncology

Caitlin Miller

Executive Director - Alzheimer’s Disease HCP Marketing
TwoStep Therapeutics

Ali Salanti

CEO, Professor
Var2 Pharmaceuticals

Jing Li

Founder and CEO
VelaVigo

Marie zhu

Chief Technology Officer
WuXi XDC

Paul Moore

Chief Scientific Officer
Zymeworks

Innovators, Regulatory Experts, Academic KOLs & ADC Afficionados

Francisco Velazquez

Senior Director, Chemistry
Abzena

Sai-Wen Tang

Executive Director of R&D
Acepodia Biotech

James Wang

Vice President & Head of Business Development
Adcendo

David Illescas

Clinical Investigator
Arrixaca University Hospital

Tiejun Li

Vice General Manager & Head, CMC & PM
AsymBio

Ruairidh Edwards

Associate Director Clinical Science & Translational Medicine
Avacta Therapeutics

Melanie Derde

Head of bioconjugation operations
Axplora

Ahmed Bassyouni

Principal Consultant
Bassyouni Consulting

Yu-Shin Hsu

Senior Research Analyst
Beacon Intelligence

Yuan-An Liu

Director, Protein & Adc Drug Product
BioNTech

David Bramhill

President & Founder
Bramhill Biological Consulting

Fabrizia Minandri

Technology Transfer Manager, Large Molecule ADCs Platform
BSP Pharmaceuticals

Jeremy Sauer

VP Strategy
Callio Therapeutics

Charles Dumontet

Deputy Director & Investigator
Cancer Research Centre of Lyon

Lena Jonsson

Product Strategy Manager
Cytiva

Olivier Cochet

Head of Pharmaceutical Development
Debiopharm

Bastiaan Duivelshof

Analytical Project Manager
Debiopharm

Nicolas Quesnot

Senior Scientist - Preclinical Safety
Debiopharm

Karan Shah

Senior Director, Analytical Development & Quality Control
Dyne Therapeutics

Andreas Nägeli

Head of Business Development
Genovis

Christian Lutz

Senior Director CMC
Heidelberg Pharma

Jesús Fuentes Antrás

Medical Oncologist & Clinical Investigator
Hospital Universitario Quirónsalud Madrid

Isabella Zampeta

Scientific Business Development Manager
HUB Organoids

Jutta Deckert

Vice President, R&D
Iksuda Therapeutics

Brian Mendelsohn

Independent Consultant
Independent Consultant

Min Hu

Senior Vice President, Oncology Discovery
Innovent Biologics

Issa Jyamubandi

Technical Expert
Intertek

Simon Jiang

Vice President of Strategy, Head of Scientific Engagement
LIDE Biotech

Matthew Sender

Director
LigaChem Biosciences

Anette Sommer

Head Bioconjugates Research
Lonza

Lisa McDermott

Director, Process & Analytical Development
Merck KGaA

Robert Andrews

ADC & Conjugate Patent Strategy (European Patent Attorney)
Mewburn Ellis LLP

Ulrich Storz

Senior Partner
Michalski · Hüttermann & Partner Patent Attorneys

Rene Hoet

Scientific Advisor
Nona Biosciences

Simon Burr

Vice President
Novo Holdings

Mattia Stucchi

R&D CDMO Manager
Olon

Hilke Zander

Clinical Assessor
Paul-Ehrlich Institut

Matilde Bocci

Research Scientist
Philochem

Nicola Beltraminelli

ADC Bioprocess Expert
Pierre Fabre

Alain BECK

Senior Director, Biologics CMC and Developability
Pierre Fabre

Conor Barry

Vice President & Global Head, Bioconjugate & Large Molecule R&D
Piramal Pharma Solutions

John Lambert

Consultant & Honorary Professor
Queen's University Belfast

Dan Shores

Partner
Rothwell Figg

Diana Hudecz

Senior Scientist
SOTIO Biotech a.s.

Colin McKee

Head, Process Development
Sterling Pharma Solutions

Allan Jordan

SVP Oncology
Sygnature Discovery

Raffaella Rossin

Vice President & Head of Preclinical Research
Tagworks Pharmaceuticals

James Baker

Professor of Chemistry
University College London

Michael Flynn

Consultant Medical Oncologist
University College London Hospital

Greg Thurber

Professor, Chemical & Biomedical Engineering
University of Michigan

Jeffrey Leyton

Associate Professor
University of Ottawa

Tobias Gustavson

Director - CMC Development
Var2 Pharmaceuticals

Thomas Rohrer

Vice President, Bioconjugation
Veranova

Conference attendees participating in a scientific presentation session at World ADC London.

Explore the Preliminary Agenda

Hear the latest industry insights and discover cutting-edge, end-to-end ADC content from early discovery to late-stage manufacturing.

View the Presentations & Speakers

Attendees meeting with exhibitors and discussing technologies at exhibition booths during World ADC London.

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options

Bub Lutz delivering a presentation on ADC innovation at the World ADC London Summit.

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.